Shared aetiology underlying multiple sclerosis and other immune mediated inflammatory diseases: Swedish familial co-aggregation and large-scale genetic correlation analyses.


Journal

Journal of autoimmunity
ISSN: 1095-9157
Titre abrégé: J Autoimmun
Pays: England
ID NLM: 8812164

Informations de publication

Date de publication:
30 Jul 2024
Historique:
received: 07 12 2023
revised: 22 06 2024
accepted: 22 07 2024
medline: 1 8 2024
pubmed: 1 8 2024
entrez: 31 7 2024
Statut: aheadofprint

Résumé

While multiple sclerosis (MS) affects less than 1 % of the general population, immune mediated inflammatory diseases (IMIDs) collectively influence 5-10 % of the population. Understanding familial co-aggregation of MS and other IMIDs carries important clinical and public health implications that will enable early detection and personalized treatment. To estimate the familial association between MS and other IMIDs and to quantify their shared genetic basis. Register-based multi-generational nested case-control familial co-aggregation study and genetic correlation study. Sweden. 24,995 individuals with MS matched with 253,870 controls and 1,283,502 first-degree relatives (mothers, fathers, full siblings, and offspring) for familial co-aggregation analysis; population of European ancestry for genetic correlation analysis. Logistic regressions with adjustment for covariates were used to estimate the odds ratios (ORs) of developing MS in individuals with first-degree relatives diagnosed with IMIDs compared to those without such family history. Pairwise genome-wide genetic correlations were estimated with linkage-disequilibrium score regression. We observed an OR for familial co-aggregation of MS of 1.09 (95 % confidence interval (95%CI) = 1.07-1.11) in families with IMIDs history compared to families without. The association remained broadly consistent after stratification by sex concordance of relative pairs and by kinships. 18 IMID subtypes showed a familial association with MS, 7 of which including other acute widespread myelin destruction, encephalitis or myelitis or encephalomyelitis, inflammatory bowel disease, autoimmune thyroid diseases, systemic lupus erythematosus, other inflammatory system diseases, and sarcoidosis withstood multiple correction. Genetic correlations further revealed a shared genetic basis between 7 IMID subtypes with MS. We demonstrated a modest familial co-aggregation of MS with several IMIDs, and such association is likely due to shared genetic factors.

Sections du résumé

BACKGROUND BACKGROUND
While multiple sclerosis (MS) affects less than 1 % of the general population, immune mediated inflammatory diseases (IMIDs) collectively influence 5-10 % of the population. Understanding familial co-aggregation of MS and other IMIDs carries important clinical and public health implications that will enable early detection and personalized treatment.
OBJECTIVE OBJECTIVE
To estimate the familial association between MS and other IMIDs and to quantify their shared genetic basis.
DESIGN METHODS
Register-based multi-generational nested case-control familial co-aggregation study and genetic correlation study.
SETTING METHODS
Sweden.
PARTICIPANTS METHODS
24,995 individuals with MS matched with 253,870 controls and 1,283,502 first-degree relatives (mothers, fathers, full siblings, and offspring) for familial co-aggregation analysis; population of European ancestry for genetic correlation analysis.
MEASUREMENTS METHODS
Logistic regressions with adjustment for covariates were used to estimate the odds ratios (ORs) of developing MS in individuals with first-degree relatives diagnosed with IMIDs compared to those without such family history. Pairwise genome-wide genetic correlations were estimated with linkage-disequilibrium score regression.
RESULTS RESULTS
We observed an OR for familial co-aggregation of MS of 1.09 (95 % confidence interval (95%CI) = 1.07-1.11) in families with IMIDs history compared to families without. The association remained broadly consistent after stratification by sex concordance of relative pairs and by kinships. 18 IMID subtypes showed a familial association with MS, 7 of which including other acute widespread myelin destruction, encephalitis or myelitis or encephalomyelitis, inflammatory bowel disease, autoimmune thyroid diseases, systemic lupus erythematosus, other inflammatory system diseases, and sarcoidosis withstood multiple correction. Genetic correlations further revealed a shared genetic basis between 7 IMID subtypes with MS.
CONCLUSION CONCLUSIONS
We demonstrated a modest familial co-aggregation of MS with several IMIDs, and such association is likely due to shared genetic factors.

Identifiants

pubmed: 39084084
pii: S0896-8411(24)00128-8
doi: 10.1016/j.jaut.2024.103294
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103294

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Qianwen Liu (Q)

Departement of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden.

Yuan Jiang (Y)

Departement of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden.

Thomas Frisell (T)

Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Solna, Sweden.

Pernilla Stridh (P)

Departement of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden.

Klementy Shchetynsky (K)

Departement of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden.

Lars Alfredsson (L)

Departement of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden; Institute of Environmental Medicine, Karolinska Institutet, Solna, Sweden.

Ingrid Kockum (I)

Departement of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden.

Ali Manouchehrinia (A)

Departement of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden. Electronic address: ali.manouchehrinia@ki.se.

Xia Jiang (X)

Departement of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden. Electronic address: xia.jiang@ki.se.

Classifications MeSH